Skip to main content

Advertisement

SpringerLink
Log in

Treatment of renal osteodystrophy in children with 1αOHD3 and 24, 25(OH)2D3

  • Original Articles
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Three pediatric patients with renal osteodystrophy were treated with 1αOHD3 and 24, 25(OH)2D3. While serum calcium level significantly decreased, no significant effects were found on serum phosphorus, alkaline phosphatase, parathyroid hormone and urinary excretion of calcium. These results suggest that 24, 25(OH)2D3 may play some roles in bone and mineral metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brickman, A.S., Coburn, J.W., Sherrard, D.J., Wong, E.G.C., Norman, A.W. and Singer, F.R.: Clinical effects of 1, 25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy. Contr. Nephrol. 18:29–41, 1980.

    CAS  Google Scholar 

  2. Massry, S.G., Goldstein, D.A. and Malluche, H.H.: Current status of the use of 1, 25(OH)2D3 in the management of renal osteodystrophy. Kidney Int., 18:409–418, 1980.

    CAS  PubMed  Google Scholar 

  3. Tsang, R.C.: 1,25-dihydroxyvitamin D3: A metabolite of vitamin D in search of a function. J. Pediatr. Gastroenterol. Nutr. 2: 581–584, 1983.

    CAS  PubMed  Google Scholar 

  4. Hodsman, A.B., Wong, E.G.C., Sherrard, D.J., Brickman, A.S., Lee, D.B.N., Singer, F.R., Norman, A.W. and Coburn, J.W.: Preliminary trials with 24, 25-dihydroxyvitamin D3 in dialysis osteomalacia. Am. J. Med., 74: 407–414, 1983.

    Article  CAS  PubMed  Google Scholar 

  5. Kanis, J.A., Taylor, C.M., Douglas, D.L., Cuntdy, T. and Russell, R.G.G.: Effects of 24, 25-dihydroxyvitamin D3 on its plasma level in man. Metab. Bone Dis. & Rel. Res. 3: 155–158, 1981.

    CAS  Google Scholar 

  6. Shimotsuji, T. and Seino, Y.: Competitive protein binding assay for 25-hydroxycholecalciferol. Methods Enzymol. 67: 466–472, 1980.

    CAS  PubMed  Google Scholar 

  7. Seino, Y., Shimotsuji, T., Yamaoka, K., et al.: Plasma 1, 25-dihydroxyvitamin D concentrations in cords, newborns, infants and children. Calcif. Tissue Int. 30: 1–3, 1980.

    CAS  PubMed  Google Scholar 

  8. Deluca, H.F. and Schnoes, H.K.: Vitamin D: Recent advances. Ann. Rev. Biochem., 52: 411–439, 1983.

    CAS  PubMed  Google Scholar 

  9. Canterbury, J.M., Gavellas, G., Bourgoignie, J.J. and Reiss, E.: Metabolic consequences of oral administration of 24, 25-dihydroxycholecalciferol to uremic dogs. J. Clin. Invest., 65: 571–576, 1980.

    CAS  PubMed  Google Scholar 

  10. Reeve, J., Tellez, M., Green, J.R., Hesp, R., Elsasser, U., Wootton, R., Hulme, P., Williams, D., Kanis, J.A., Russell, R.G.G., Mawer, E.B. and Meunier, P.J.: Lontterm treatment of osteoporosis with 24, 25 dihydroxycholecalciferol, Acta Endocrinol. 101: 636–640, 1982.

    CAS  PubMed  Google Scholar 

  11. Okamoto, S., Tanaka, Y., DeLuca, H.F., Yamada, S. and Takayama, H.: 24, 24-difluoro-25-hydroxy-vitamin D3 -enhanced bone mineralization in rats. Comparison with 25-hydroxy-vitamin D3 and vitamin D3, Arch. Biochem. Biophys., 206: 8–14, 1981.

    Article  CAS  PubMed  Google Scholar 

  12. Ameenuddin, S., Sunde, M., DeLuca, H.F., Ikekawa, N. and Kobayashi, Y.: 24-hydroxylation of 25-hydroxyvitamin D3: Is it required for embryonic development in chicks?, Science, 217: 451–452, 1982.

    CAS  PubMed  Google Scholar 

  13. Walling, M.W., Hartenbower, D.L., Coburn, J.W. and Norman, A.W.: Effects of 1, 25-, 24R, 25-, and 1, 24R, 25-hydroxylated metabolites of vitamin D3 on calcium and phosphate absorption by duodenum from intact and nephrectomized rats. Arch. Biochem. Biophys. 182: 251–257, 1977.

    Article  CAS  PubMed  Google Scholar 

  14. Henry, H.L. and Norman, A.W.: Vitamin D: Two dihydroxylated metabolites are required for normal chicken egg hatchability. Science, 201: 835–837, 1978.

    CAS  PubMed  Google Scholar 

  15. Pavlovitch, J.H., Witmer, G.C., Bourdeau, A., Balsan, S., Fisher, J.A. and Heynen, G.: Suppressive effects of 24,25-dihydroxycholecalciferol on bone resorption induced by acute bilateral nephrectomy in rats., J. Clin. Invest., 68: 803–810, 1981.

    CAS  PubMed  Google Scholar 

  16. Corvol, M.T., Dumontier, M.F., Garabedian, M. and Rappaport, R.: Vitamin D and cartilage. II. Biological activity of 25-hydroxycholecalciferol and 24, 25-and 1, 25-dihydroxycholecalciferols on cultured growth plate chondrocytes, Endocrinology 102: 1269–1274, 1978.

    CAS  Google Scholar 

  17. Malluche, H.H., Henry, H., Meyer-Sabellek, W., Sherman, D., Massry, S.G. and Norman, A.W.: Effects and interaction of 24R, 25(OH)2D3 and 1, 25(OH)2D3 on bone, Am. J. Physiol. 238: E494-E498, 1980.

    CAS  PubMed  Google Scholar 

  18. Satomura, K., Seino, Y., Shima, M., Tanaka, H., Tanaka, Y., Yamaoka, K., Ishida, M., Yabuuchi, H., Goto, M. and Sumi, K.: Growth failure and bone disease in renal failure, Nippon Shonikagakkai Zasshi 88: 2756–2762, 1984.

    Google Scholar 

  19. Freundlich, M., Zilleruelo, G., Abitbol, C., Hwang, K. H., Bourgoignie, J.J. and Strauss, J.: Minerals and bone-modulating hormones in children on continuous ambulatory peritoneal dialysis, Nephron 41: 267–272, 1985.

    CAS  PubMed  Google Scholar 

  20. Paunier, L., Salusky, I.B., Slatopolsky, E., Kangarloo, H., Kopple, J.D., Horst, R.L., Coburn, J.W. and Fine, R.N.: Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis, Pediatr. Res. 18: 742–747, 1984.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Osaka University School of Medicine, 1-1-50, Fukushima, Fukushima-ku, 553, Osaka, Japan

    Keiichi Ohzono, Yoshiki Seino, Makoto Ishida, Kenichi Satomura, Hirofumi Kurose, Hiroyuki Tanaka, Takehisa Yamamoto, Masaaki Shima, Kanji Yamaoka & Hyakuji Yabuuchi

  2. Aizenbashi Hospital, Osaka, Japan

    Yoshiyuki Tanaka

Authors
  1. Keiichi Ohzono
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshiki Seino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Makoto Ishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenichi Satomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hirofumi Kurose
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroyuki Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takehisa Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masaaki Shima
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kanji Yamaoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hyakuji Yabuuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yoshiyuki Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Ohzono, K., Seino, Y., Ishida, M. et al. Treatment of renal osteodystrophy in children with 1αOHD3 and 24, 25(OH)2D3 . J Bone Miner Metab 6, 21–25 (1988). https://doi.org/10.1007/BF02378735

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02378735

Key words

Search

Navigation